Insilico collaborates with Pfizer on novel data and AI system for target discovery

The last collaboration of the famous Insilico Medicine Hong Kong company is the Pfizer laboratories. After a very busy year 2019 with publications in Nature Biotechnology and more than 35 millions dollars rond, the company increase partnership in the pharmaceutical domain. His patented technology is focused on the use of AI algorithms to find best combinations between drugs and molecular targets. This way to find new drugs could be the game changer in the future…

"Insilico collaborates with Pfizer on novel data and AI system for target discovery"